======= GNS =======
== Gene Information ==
* **Official Symbol**: GNS
* **Official Name**: glucosamine (N-acetyl)-6-sulfatase
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2799|2799]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P15586|P15586]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=GNS&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GNS|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607664|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The product of this gene is a lysosomal enzyme found in all cells. It is involved in the catabolism of heparin, heparan sulphate, and keratan sulphate. Deficiency of this enzyme results in the accumulation of undegraded substrate and the lysosomal storage disorder mucopolysaccharidosis type IIID (Sanfilippo D syndrome). Mucopolysaccharidosis type IIID is the least common of the four subtypes of Sanfilippo syndrome. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: N/A
|Sulfatase|
|N-acetylglucosamine-6-sulfatase activity|
|sulfuric ester hydrolase activity|
|keratan sulfate catabolic process|
|glycosaminoglycan binding|
|keratan sulfate metabolic process|
|sulfur compound catabolic process|
|glycosaminoglycan catabolic process|
|aminoglycan catabolic process|
|azurophil granule lumen|
|lysosomal lumen|
|mucopolysaccharide metabolic process|
|ficolin-1-rich granule lumen|
|glycosaminoglycan metabolic process|
|aminoglycan metabolic process|
|carbohydrate derivative catabolic process|
|sulfur compound metabolic process|
|neutrophil degranulation|
|neutrophil activation involved in immune response|
|neutrophil mediated immunity|
|neutrophil activation|
|granulocyte activation|
|leukocyte degranulation|
|myeloid leukocyte mediated immunity|
|myeloid cell activation involved in immune response|
|myeloid leukocyte activation|
|leukocyte activation involved in immune response|
|cell activation involved in immune response|
|regulated exocytosis|
|leukocyte mediated immunity|
|exocytosis|
|leukocyte activation|
|oxoacid metabolic process|
|secretion by cell|
|organic acid metabolic process|
|carbohydrate derivative metabolic process|
|export from cell|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|cell activation|
|immune effector process|
|secretion|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
|immune response|
|extracellular region|
|vesicle-mediated transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp165|RO-3306 3 to 4μM on day4 R04 exp165]]|-1.72|
|[[:results:exp210|LB-100 2μM R05 exp210]]|2.09|
|[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|2.38|
|[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|2.44|
^Gene^Correlation^
|[[:human genes:r:ruvbl2|RUVBL2]]|0.405|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 12058
* **Expression level (log2 read counts)**: 6.39
{{:chemogenomics:nalm6 dist.png?nolink |}}